DOUBLE-BLIND COMPARISON OF THE ACUTE EFFECTS OF 2 RELEVANT DOSES OF ORAL NICORANDIL ON CENTRAL HEMODYNAMICS, LEFT-VENTRICULAR FUNCTION, ANDMYOCARDIAL-CONTRACTILITY
A. Baumbach et al., DOUBLE-BLIND COMPARISON OF THE ACUTE EFFECTS OF 2 RELEVANT DOSES OF ORAL NICORANDIL ON CENTRAL HEMODYNAMICS, LEFT-VENTRICULAR FUNCTION, ANDMYOCARDIAL-CONTRACTILITY, Cardiovascular drugs and therapy, 9, 1995, pp. 213-220
Citations number
19
Categorie Soggetti
Pharmacology & Pharmacy","Cardiac & Cardiovascular System
Nicorandil is a nicotinamide derivative with potent vasodilator proper
ties. Oral and sublingual administration of this compound in patients
with coronary artery disease resulted in a predominant reduction of af
terload and a small decrease in left ventricular preload. The effects
of nicorandil in different doses on contractile left ventricular (LV)
function, however, are not well defined. The aim of the present study
was to assess the effects of nicorandil on hemodynamics, left ventricu
lar volume and function, as well as the LV contractility index dP/dt m
easured by Millar-tip manometers, A total of 16 patients with coronary
artery disease were included in this study, After diagnostic coronary
angiography and ventriculography, the patients randomly received eith
er 10 or 20 mg of oral nicorandil. The hemodynamic parameters, cardiac
output, and LV end-diastolic and systolic pressures were determined a
fter 15, 30, and 60 minutes, and a second angiogram was performed 60 m
inutes after administration. The predominant effect was a decrease in
the mean aortic pressure with a concomitant decrease in the peripheral
arterial resistance. Clinically relevant changes in aortic pressure,
systemic vascular resistance, and rate-pressure product, however, were
documented only after oral administration of 20 mg nicorandil, as opp
osed to minimal changes in the 10 mg group. LV volume and cardiac outp
ut were not changed significantly. LV contractility remained unchanged
during the observation period. The hemodynamic profile of this compou
nd is dose-dependent afterload reduction without a change in contracti
lity. Because there was no concomitant increase in heart rate, calcula
ted oxygen consumption was reduced, especially in the higher dose grou
p.